Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
5/2/2007
1.
Phase III Chemotherapy with ADR and with Combinations of ACT-D, L-PAM, VCR and CYL for Soft Tissue and Osseous Sarcomas (Summary Last Modified 10/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
16 to 80
CENOG-7231
2.
Phase I and II Chemotherapy with Cycloleucine for Disseminated Malignant Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
no age specified
WSU-C-21977
3.
Phase II Chemotherapy with Cycloleucine for Disseminated Large Bowel Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
WSU-C-34380
4.
Phase II Chemotherapy with Cycloleucine for Carcinoma of the Colon, Rectum, Ovary, Melanomas and Sarcomas
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
15 to 70
CENOG-7122
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute